Sesen Bio Inc (SESN)

Sesen Bio (SESN) Stock Price & Analysis


SESN Stock Chart & Stats

Day’s Range$11.4 - $12.576
52-Week Range― - ―
Previous Close$11.72
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding202,759,043
10 Day Avg. Volume927,532
30 Day Avg. Volume835,867
Standard Deviation0.35
Financial Highlights & Ratios
Price to Book (P/B)0.75
Price to Sales (P/S)3.09
Price to Cash Flow (P/CF)12.70
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Sesen Bio Inc’s price range in the past 12 months?
Currently, no data Available
What is Sesen Bio Inc’s market cap?
Currently, no data Available
When is Sesen Bio Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sesen Bio Inc’s earnings last quarter?
Currently, no data Available
Is Sesen Bio Inc overvalued?
According to Wall Street analysts Sesen Bio Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Sesen Bio Inc pay dividends?
    Sesen Bio Inc does not currently pay dividends.
    What is Sesen Bio Inc’s EPS estimate?
    Sesen Bio Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Sesen Bio Inc have?
    Currently, no data Available
    What happened to Sesen Bio Inc’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Sesen Bio Inc?
    Among the largest hedge funds holding Sesen Bio Inc’s share is Caxton Associates LP. It holds Sesen Bio Inc’s shares valued at N/A.


      Sesen Bio Stock Smart Score

      This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
      Learn more about TipRanks Smart Score

      Company Description

      Sesen Bio Inc

      Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Inmune Bio

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis